The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year.
This report contains market size and forecasts of Diabetic Therapeutic in Global, including the following market information:
Global Diabetic Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetic Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sulphonylureas Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Therapeutic include Sanofi, Novo Nordisk, MSD, Astrazeneca, Takeda, Novartis, AbbVie, Eli Lilly and North China Pharmaceutical Group Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Therapeutic Market Segment Percentages, by Type, 2021 (%)
Sulphonylureas
Biguanides
Meglitinides
Thiazolidinediones
Alpha-glucosidase Inhibitors
DPP-4 Inhibitors
SGLT-2 Inhibitors
Global Diabetic Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Diabetic Therapeutic Market Segment Percentages, by Application, 2021 (%)
Diagnostic/Clinics
ICUs
Home Healthcare
Global Diabetic Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Diabetic Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetic Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetic Therapeutic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Novo Nordisk
MSD
Astrazeneca
Takeda
Novartis
AbbVie
Eli Lilly
North China Pharmaceutical Group Corporation
Huadong Medicine
Dongbao Pharmaceutical
Hisun Pharmacy
KELUN
Ginwa
Tianan Pharmaceutical
Jumpcan Pharmacy
Guangzhou Baiyun Mountain
SHIJIAZHUANG YILING PHARMACEUTICAL
Wanbang Biopharmaceuticals
Gan & Lee
Taloph